BRTX
Price
$1.79
Change
+$0.05 (+2.87%)
Updated
Apr 11 closing price
Capitalization
12.01M
38 days until earnings call
ETNB
Price
$5.53
Change
+$0.54 (+10.82%)
Updated
Apr 11 closing price
Capitalization
807.29M
25 days until earnings call
Ad is loading...

BRTX vs ETNB

Header iconBRTX vs ETNB Comparison
Open Charts BRTX vs ETNBBanner chart's image
BioRestorative Therapies
Price$1.79
Change+$0.05 (+2.87%)
Volume$18.36K
Capitalization12.01M
89bio
Price$5.53
Change+$0.54 (+10.82%)
Volume$1.83M
Capitalization807.29M
BRTX vs ETNB Comparison Chart
Loading...
BRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BRTX vs. ETNB commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRTX is a Hold and ETNB is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 12, 2025
Stock price -- (BRTX: $1.79 vs. ETNB: $5.53)
Brand notoriety: BRTX and ETNB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRTX: 4% vs. ETNB: 89%
Market capitalization -- BRTX: $12.01M vs. ETNB: $807.29M
BRTX [@Biotechnology] is valued at $12.01M. ETNB’s [@Biotechnology] market capitalization is $807.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.66B to $0. The average market capitalization across the [@Biotechnology] industry is $1.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRTX’s FA Score shows that 0 FA rating(s) are green whileETNB’s FA Score has 0 green FA rating(s).

  • BRTX’s FA Score: 0 green, 5 red.
  • ETNB’s FA Score: 0 green, 5 red.
According to our system of comparison, BRTX is a better buy in the long-term than ETNB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRTX’s TA Score shows that 3 TA indicator(s) are bullish while ETNB’s TA Score has 4 bullish TA indicator(s).

  • BRTX’s TA Score: 3 bullish, 5 bearish.
  • ETNB’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both BRTX and ETNB are a bad buy in the short-term.

Price Growth

BRTX (@Biotechnology) experienced а +5.29% price change this week, while ETNB (@Biotechnology) price change was -4.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.15%. For the same industry, the average monthly price growth was -16.20%, and the average quarterly price growth was -17.21%.

Reported Earning Dates

BRTX is expected to report earnings on Aug 19, 2025.

ETNB is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+0.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ETNB($807M) has a higher market cap than BRTX($12M). BRTX YTD gains are higher at: 25.175 vs. ETNB (-29.284). BRTX has higher annual earnings (EBITDA): -11.9M vs. ETNB (-361.06M). ETNB has more cash in the bank: 440M vs. BRTX (13.1M). BRTX has less debt than ETNB: BRTX (42.4K) vs ETNB (37.5M). BRTX has higher revenues than ETNB: BRTX (377K) vs ETNB (0).
BRTXETNBBRTX / ETNB
Capitalization12M807M1%
EBITDA-11.9M-361.06M3%
Gain YTD25.175-29.284-86%
P/E RatioN/AN/A-
Revenue377K0-
Total Cash13.1M440M3%
Total Debt42.4K37.5M0%
FUNDAMENTALS RATINGS
BRTX: Fundamental Ratings
BRTX
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
99
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BRTXETNB
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 17 days ago
85%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 5 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Ad is loading...
BRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SIDNX10.21N/A
N/A
Hartford Schroders Intl Multi-Cp Val I
MIGHX36.92N/A
N/A
MFS Massachusetts Inv Gr Stk R3
CAHEX16.39N/A
N/A
Calamos Hedged Equity A
SUVQX11.23N/A
N/A
PGIM Quant Solutions Large-Cap Val R6
JNDVX10.62N/A
N/A
Janus Henderson U.S. Dividend Income N

BRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRTX has been loosely correlated with TCRT. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if BRTX jumps, then TCRT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRTX
1D Price
Change %
BRTX100%
+3.17%
TCRT - BRTX
33%
Loosely correlated
+2.10%
URGN - BRTX
31%
Poorly correlated
+7.77%
CERO - BRTX
29%
Poorly correlated
-9.10%
IMRX - BRTX
28%
Poorly correlated
+4.03%
GRCE - BRTX
28%
Poorly correlated
+2.06%
More

ETNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETNB has been loosely correlated with AKRO. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ETNB jumps, then AKRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETNB
1D Price
Change %
ETNB100%
+10.71%
AKRO - ETNB
59%
Loosely correlated
+2.43%
RCKT - ETNB
56%
Loosely correlated
+6.68%
IDYA - ETNB
51%
Loosely correlated
+6.21%
NTLA - ETNB
51%
Loosely correlated
+9.45%
DNLI - ETNB
50%
Loosely correlated
+1.60%
More